Klein TW - Search Results

1

Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection.

Williams JC, Appelberg S, Goldberger BA, Klein TW, Sleasman JW, Goodenow MM. Williams JC, et al. Among authors: klein tw. J Neuroimmune Pharmacol. 2014 Jun;9(3):369-79. doi: 10.1007/s11481-014-9527-3. Epub 2014 Feb 23. J Neuroimmune Pharmacol. 2014. PMID: 24562630 Free PMC article.

2

Δ(9)-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles.

Williams JC, Klein TW, Goldberger BA, Sleasman JW, Mackman N, Goodenow MM. Williams JC, et al. Among authors: klein tw. J Inflamm (Lond). 2015 Jun 12;12:39. doi: 10.1186/s12950-015-0084-1. eCollection 2015. J Inflamm (Lond). 2015. PMID: 26085816 Free PMC article.

3

CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9-tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection.

Newton CA, Chou PJ, Perkins I, Klein TW. Newton CA, et al. Among authors: klein tw. J Neuroimmune Pharmacol. 2009 Mar;4(1):92-102. doi: 10.1007/s11481-008-9126-2. Epub 2008 Sep 16. J Neuroimmune Pharmacol. 2009. PMID: 18792785

4

delta 9-Tetrahydrocannabinol (THC) modulates IL-1 bioactivity in human monocyte/macrophage cell lines.

Shivers SC, Newton C, Friedman H, Klein TW. Shivers SC, et al. Among authors: klein tw. Life Sci. 1994;54(17):1281-9. doi: 10.1016/0024-3205(94)00856-6. Life Sci. 1994. PMID: 8164509

5

Cannabinoid-induced immune suppression and modulation of antigen-presenting cells.

Klein TW, Cabral GA. Klein TW, et al. J Neuroimmune Pharmacol. 2006 Mar;1(1):50-64. doi: 10.1007/s11481-005-9007-x. J Neuroimmune Pharmacol. 2006. PMID: 18040791 Review.

6

Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes.

Agudelo M, Newton C, Widen R, Sherwood T, Nong L, Friedman H, Klein TW. Agudelo M, et al. Among authors: klein tw. J Neuroimmune Pharmacol. 2008 Mar;3(1):35-42. doi: 10.1007/s11481-007-9088-9. Epub 2007 Sep 27. J Neuroimmune Pharmacol. 2008. PMID: 18247126 Free PMC article.

7

Cannabinoid 2 (CB2) receptor involvement in the down-regulation but not up-regulation of serum IgE levels in immunized mice.

Newton CA, Klein TW. Newton CA, et al. Among authors: klein tw. J Neuroimmune Pharmacol. 2012 Sep;7(3):591-8. doi: 10.1007/s11481-012-9361-4. Epub 2012 May 4. J Neuroimmune Pharmacol. 2012. PMID: 22552780 Free PMC article.

8

Enhanced growth of Legionella pneumophila in tetrahydrocannabinol-treated macrophages.

Arata S, Newton C, Klein T, Friedman H. Arata S, et al. Proc Soc Exp Biol Med. 1992 Jan;199(1):65-7. doi: 10.3181/00379727-199-43330. Proc Soc Exp Biol Med. 1992. PMID: 1309398

9

Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro.

Medveczky MM, Sherwood TA, Klein TW, Friedman H, Medveczky PG. Medveczky MM, et al. Among authors: klein tw. BMC Med. 2004 Sep 15;2:34. doi: 10.1186/1741-7015-2-34. BMC Med. 2004. PMID: 15369590 Free PMC article.

10

Role of cannabinoid receptors in Delta-9-tetrahydrocannabinol suppression of IL-12p40 in mouse bone marrow-derived dendritic cells infected with Legionella pneumophila.

Lu T, Newton C, Perkins I, Friedman H, Klein TW. Lu T, et al. Among authors: klein tw. Eur J Pharmacol. 2006 Feb 17;532(1-2):170-7. doi: 10.1016/j.ejphar.2005.12.040. Epub 2006 Jan 27. Eur J Pharmacol. 2006. PMID: 16443217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters